Patents by Inventor Marianna Zinovjevna Kapitskaya

Marianna Zinovjevna Kapitskaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ecdysone receptor-based inducible gene expression system
    Patent number: 8822754
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: September 2, 2014
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Novel Ecdysone Receptor-Based Inducible Gene Expression System
    Publication number: 20120322148
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: May 3, 2012
    Publication date: December 20, 2012
    Applicant: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
    Patent number: 8236556
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: August 7, 2012
    Assignee: Intrexon Corporation
    Inventors: Marianna Zinovjevna Kapitskaya, Subba Reddy Palli
  • Ecdysone receptor-based inducible gene expression system
    Patent number: 8202718
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: June 19, 2012
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Novel Ecdysone Receptor-Based Inducible Gene Expression System
    Publication number: 20110059525
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: June 17, 2010
    Publication date: March 10, 2011
    Applicant: INTREXON CORPORATION
    Inventors: SUBBA REDDY PALLI, MARIANNA ZINOVJEVNA KAPITSKAYA, DEAN ERVIN CRESS
  • Novel Ecdysone Receptor-Based Inducible Gene Expression System
    Publication number: 20110059530
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: August 20, 2010
    Publication date: March 10, 2011
    Applicant: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Ecdysone receptor-based inducible gene expression system
    Patent number: 7807417
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: October 5, 2010
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Ecdysone receptor-based inducible gene expression system
    Patent number: 7776587
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: August 17, 2010
    Assignee: Intrexon Corporation
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
    Patent number: 7531326
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation traits in transgenic organisms.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: May 12, 2009
    Assignee: Intrexon Corporation
    Inventors: Marianna Zinovjevna Kapitskaya, Subba Reddy Palli
  • CHIMERIC RETINOID X RECEPTORS AND THEIR USE IN A NOVEL ECDYSONE RECEPTOR-BASED INDUCIBLE GENE EXPRESSION SYSTEM
    Publication number: 20080176280
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
    Type: Application
    Filed: August 20, 2007
    Publication date: July 24, 2008
    Inventors: Marianna Zinovjevna Kapitskaya, Subba Reddy Palli
  • Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
    Publication number: 20040096942
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation traits in transgenic organisms.
    Type: Application
    Filed: December 17, 2003
    Publication date: May 20, 2004
    Inventors: Marianna Zinovjevna Kapitskaya, Subba Reddy Palli
  • Ecdysone receptor-based inducible gene expression system
    Publication number: 20040033600
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: September 19, 2002
    Publication date: February 19, 2004
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress
  • Novel ecdysone receptor-based inducible gene expression system
    Publication number: 20020119521
    Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals.
    Type: Application
    Filed: September 26, 2001
    Publication date: August 29, 2002
    Inventors: Subba Reddy Palli, Marianna Zinovjevna Kapitskaya, Dean Ervin Cress